NICE Talks is the podcast from UK's National Institute of Health and Care Excellence (NICE). Our podcast brings the stories behind our work to improve outcomes for people using the NHS and other public health and social care services through evidence-based guidance. Subscribe on your favourite podcast platform: https://linktr.ee/nicecomms
Subscribe:.rss.atom.json.md.m3u.pls
Live Last read · last published · next check
Saves to your Listen queue, to pick up on another day or another device.
In this episode we explore the draft NICE guideline for PMOS (formerly known as PCOS), out for public consultation until 11 August 2026. We're joined by guideline committee members Aled Rees, professor of endocrinology at Cardiff University, and Sharon Manship, a lay member with lived experience of PMOS. Together they discuss how the recent name change, a new annual review, and a stronger focus on…
NICE has recommended teplizumab for NHS use — the first treatment to delay the onset of symptomatic type 1 diabetes by an average of nearly three years. In this episode, we speak to Lucy Chambers, Head of Research Impact and Communications at Diabetes UK, and Amy Norman, whose daughter Imogen accessed teplizumab through a managed access programme after being identified through the ELSA screening…
In this episode we discuss the recent changes to the NICE guideline for neonatal infections, that mean newborn babies receiving antibiotics in hospital could potentially switch to oral antibiotics and be cared for at home, if they are doing well and responding to treatment. Guests: • Dr Tim Watts, guideline committee member and Consultant Neonatologist at the Evelina • Dr Harriet Aughey, Neonatal…
In this episode of NICE Talks, we're covering some of the most significant guidance updates of the year so far for women's health and cancer care. For the first time, NICE's updated fertility guideline includes a dedicated pathway specifically for people with endometriosis who are trying to conceive — a direct result of patient and clinician voices being heard during public consultation. We then…
When the right technology reaches the right patient, lives change. In this episode of NICE Talks, we hear directly from people whose lives have been transformed by NICE-recommended healthtech, including a hybrid closed loop system for type 1 diabetes, an implantable cardiac monitor to detect atrial fibrillation following a stroke, and a rapid genetic test that protects newborns from hearing loss…
In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid uptake across the NHS with our three guests. We're joined by Joanne McShane, an NHS health visitor who suffered from migraine for a decade; Dr Kay Kennis, GP with an extended role in Headache at Bradford Community Neurology Service; and Rob Music, chief executive at The Migraine Trust.
In this episode of NICE Talks, we learn the impact of the joint asthma guideline published in November 2024. Developed collaboratively by the British Thoracic Society, NICE and the Scottish Intercollegiate Guidelines Network, the guideline has transformed how asthma is diagnosed and treated across the UK. We hear from frontline clinicians putting the guidance into practice and from those who…
We look back on the guidance we've produced in 2025. We're joined by director of medicines evaluation Helen Knight, the deputy director of the centre for guidelines Eric Power, and Anastasia Chalkidou, the programme director of guidance delivery in HealthTech.
We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway. Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4
In this episode we learn how NICE is helping to deliver the government's 10 year health plan. Our guests are the senior responsible officers looking after the three NICE projects. They are: associate director for planning and operations Jenna Dilkes; deputy director for HealthTech Sarah Byron; anddeputy director for medicines evaluation Jac Bouvy.
